Andrew Kaiser

5.6k total citations · 1 hit paper
56 papers, 4.3k citations indexed

About

Andrew Kaiser is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Andrew Kaiser has authored 56 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 33 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Andrew Kaiser's work include CAR-T cell therapy research (46 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (19 papers). Andrew Kaiser is often cited by papers focused on CAR-T cell therapy research (46 papers), Immunotherapy and Immune Responses (23 papers) and Immune Cell Function and Interaction (19 papers). Andrew Kaiser collaborates with scholars based in Germany, United States and Netherlands. Andrew Kaiser's co-authors include Nicholas P. Restifo, Chrystal M. Paulos, Luca Gattinoni, Douglas C. Palmer, Claudia Wrzesinski, Pawel Muranski, Steven A. Rosenberg, Christian S. Hinrichs, Zhiya Yu and Lydie Cassard and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Andrew Kaiser

56 papers receiving 4.2k citations

Hit Papers

Tumor-specific Th17-polarized cells eradicate large estab... 2008 2026 2014 2020 2008 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor-specific Th17-polarized cells eradicate large established melanoma
    2008 638 citations Pawel Muranski, Andrea Boni et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Kaiser Germany 31 3.1k 2.6k 1.2k 867 546 56 4.3k
Leonid S. Metelitsa United States 34 2.8k 0.9× 2.6k 1.0× 1.2k 1.0× 617 0.7× 570 1.0× 57 4.6k
David E. Gilham United Kingdom 35 3.0k 1.0× 1.6k 0.6× 1.1k 0.9× 808 0.9× 861 1.6× 90 3.7k
Claudia Wrzesinski United States 16 2.8k 0.9× 2.9k 1.1× 934 0.8× 644 0.7× 254 0.5× 20 4.1k
Sourindra N. Maiti United States 25 2.0k 0.6× 1.3k 0.5× 1.7k 1.4× 806 0.9× 471 0.9× 46 3.5k
Yun Ji United States 28 3.4k 1.1× 3.9k 1.5× 2.0k 1.8× 856 1.0× 519 1.0× 54 6.3k
Paul A. Antony United States 25 4.6k 1.5× 5.3k 2.0× 1.3k 1.1× 836 1.0× 312 0.6× 35 7.0k
Sid P. Kerkar United States 19 2.1k 0.7× 1.6k 0.6× 628 0.5× 637 0.7× 418 0.8× 36 2.7k
Andreas Hombach Germany 42 4.5k 1.4× 2.5k 1.0× 1.4k 1.2× 1.4k 1.6× 1.3k 2.4× 104 5.4k
Brian Rabinovich United States 27 1.6k 0.5× 1.7k 0.7× 1.1k 0.9× 379 0.4× 327 0.6× 45 3.3k
Markus Chmielewski Germany 30 3.5k 1.1× 1.7k 0.6× 1.1k 0.9× 1.0k 1.2× 1.2k 2.1× 38 4.0k

Countries citing papers authored by Andrew Kaiser

Since Specialization
Citations

This map shows the geographic impact of Andrew Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Kaiser more than expected).

Fields of papers citing papers by Andrew Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Kaiser. The network helps show where Andrew Kaiser may publish in the future.

Co-authorship network of co-authors of Andrew Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Kaiser. A scholar is included among the top collaborators of Andrew Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Kaiser. Andrew Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaiser, Andrew, et al.. (2023). Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma. Frontiers in Immunology. 14. 1178060–1178060. 5 indexed citations
2.
Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1. Cancer Immunology Research. 9(12). 1425–1438. 51 indexed citations
3.
Krueger, Winfried, André Roy, Wa’el Al Rawashdeh, et al.. (2021). Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors. Cancers. 13(19). 4741–4741. 13 indexed citations
4.
Lock, Dominik, Franziska Blaeschke, Sandra Karitzky, et al.. (2021). Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Molecular Therapy — Methods & Clinical Development. 21. 42–53. 10 indexed citations
5.
Seitz, Christian, Stefan Grote, Dominik Lock, et al.. (2018). Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles. Blood. 132(Supplement 1). 4543–4543. 8 indexed citations
6.
7.
Lock, Dominik, Nadine Mockel-Tenbrinck, Daniela Mauer, et al.. (2017). Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Human Gene Therapy. 28(10). 914–925. 85 indexed citations
8.
Seitz, Christian, Patrick Schlegel, Sarah M. Schroeder, et al.. (2017). Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens. Blood. 130. 1912–1912. 3 indexed citations
9.
Bowers, Jacob S., Michelle H. Nelson, Kinga Majchrzak, et al.. (2017). Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion. JCI Insight. 2(5). e90772–e90772. 50 indexed citations
10.
Mock, Ulrike, Lauren Nickolay, Brian Philip, et al.. (2016). Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy. Cytotherapy. 18(8). 1002–1011. 163 indexed citations
11.
Kerkar, Sid P., Luis Sánchez-Pérez, Shicheng Yang, et al.. (2011). Genetic Engineering of Murine CD8+ and CD4+ T Cells for Preclinical Adoptive Immunotherapy Studies. Journal of Immunotherapy. 34(4). 343–352. 76 indexed citations
12.
Kerkar, Sid P., Pawel Muranski, Andrew Kaiser, et al.. (2010). Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts. Cancer Research. 70(17). 6725–6734. 207 indexed citations
13.
Wrzesinski, Claudia, Chrystal M. Paulos, Andrew Kaiser, et al.. (2009). Increased Intensity Lymphodepletion Enhances Tumor Treatment Efficacy of Adoptively Transferred Tumor-specific T Cells. Journal of Immunotherapy. 33(1). 1–7. 211 indexed citations
14.
Muranski, Pawel, Andrea Boni, Paul A. Antony, et al.. (2008). Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood. 112(2). 362–373. 638 indexed citations breakdown →
15.
Witte, Moniek A. de, Annelies Jorritsma, Andrew Kaiser, et al.. (2008). Requirements for Effective Antitumor Responses of TCR Transduced T Cells. The Journal of Immunology. 181(7). 5128–5136. 46 indexed citations
16.
Paulos, Chrystal M., Claudia Wrzesinski, Andrew Kaiser, et al.. (2007). Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. Journal of Clinical Investigation. 117(8). 2197–2204. 452 indexed citations
17.
Antony, Paul A., Chrystal M. Paulos, Mojgan Ahmadzadeh, et al.. (2006). Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo. The Journal of Immunology. 176(9). 5255–5266. 101 indexed citations
18.
Kaiser, Andrew, Emmanuel Donnadieu, Jean‐Pierre Abastado, Alain Trautmann, & Alessandra Nardin. (2005). CC Chemokine Ligand 19 Secreted by Mature Dendritic Cells Increases Naive T Cell Scanning Behavior and Their Response to Rare Cognate Antigen. The Journal of Immunology. 175(4). 2349–2356. 77 indexed citations
19.
20.
Kaiser, Andrew, Nadège Bercovici, Jean‐Pierre Abastado, & Alessandra Nardin. (2002). Naive CD8+ T cell recruitment and proliferation are dependent on stage of dendritic cell maturation. European Journal of Immunology. 33(1). 162–171. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonid S. Metelitsa Breakdown of academic impact, for papers by David E. Gilham Breakdown of academic impact, for papers by Claudia Wrzesinski Breakdown of academic impact, for papers by Sourindra N. Maiti Breakdown of academic impact, for papers by Yun Ji Breakdown of academic impact, for papers by Paul A. Antony Breakdown of academic impact, for papers by Sid P. Kerkar Breakdown of academic impact, for papers by Andreas Hombach Breakdown of academic impact, for papers by Brian Rabinovich Breakdown of academic impact, for papers by Markus Chmielewski
Rankless by CCL
2026